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Abstract
Background: Modern functional genomic approaches may help to better understand the molecular events
involved in tissue morphogenesis and to identify molecular signatures and pathways. We have recently applied
transcriptomic profiling to evidence molecular signatures in the development of the normal chicken chorioallantoic
membrane (CAM) and in tumor engrafted on the CAM. We have now extended our studies by performing a
transcriptome analysis in the “wound model” of the chicken CAM, which is another relevant model of tissue
morphogenesis.
Results: To induce granulation tissue (GT) formation, we performed wounding of the chicken CAM and compared
gene expression to normal CAM at the same stage of development. Matched control samples from the same
individual were used. We observed a total of 282 genes up-regulated and 44 genes down-regulated assuming a
false-discovery rate at 5% and a fold change > 2. Furthermore, bioinformatics analysis lead to the identification of
several categories that are associated to organismal injury, tissue morphology, cellular movement, inflammatory
disease, development and immune system. Endothelial cell data filtering leads to the identification of several new
genes with an endothelial cell signature.
Conclusions: The chick chorioallantoic wound model allows the identification of gene signatures and pathways
involved in GT formation and neoangiogenesis. This may constitute a fertile ground for further studies.
Background
Different physiological as well as pathological conditions
trigger tissue remodeling including surgery, infection,
chemical or physical burns, ischemia or immunological
reaction [1]. The restoration of tissue integrity involves
alteration in tissue elasticity, interstitial fluid pressure
and oxygen tension, which is normalized by vasculariza-
tion of the affected region [2]. Revascularization is
accomplished by the ingrown of the granulation tissue
(GT) that is composed of a dense network of enlarged
vessels forming specific and leaky temporary vasculature
[3]. When not disturbed, GT vasculature is normalized
during course of scarification. The healing process pro-
ceeds according to that general pattern e.g. in the skin
but also during regenerative healing after brain or myo-
cardium stroke [4]. Wound healing can be perturbed by
pathological changes that include ulceration, hyper-
trophic scaring or keloids formation and fibrosis [5].
Modern therapy requires the targeting of drugs directly
to the site of interest and to accomplish that goal in sys-
temic treatment, the molecular signatures distinguishing
the expanding vasculature of the GT from the normal
vessels need to be known.
The chicken embryo model has been widely used in
developmental biology to understand vascular develop-
ment and to test the effect of molecules predicted to
interfere with the angiogenic process or lymphangiogen-
esis [6]. For example, the effect of flow on vessel ontol-
ogy such as venous or arterial patterning has been
elucidated using the chicken chorioallantoic membrane
(CAM) [7]. Furthermore, the effect of different angio-
genesis stimulators such as VEGF-A, VEGF-C or inhibi-
tors has been tested in the chick embryo. Adult wound
healing involves movement from the epidermis and con-
nective tissue and the recruitment of inflammatory and
immunocompetent cells. Embryonic wound healing also
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any medium, provided the original work is properly cited.involves wound contraction, followed by re-epithelializa-
tion but without recruitment of immunocompetent
cells. The inflammatory response in wound healing is
crucial for fighting infection so that tissue damage does
not lead to death through septicaemia. But, aside from
this role, recruitment of leukocytes may more negatively
impact wound healing. Indeed, knockout and knock-
down studies suggest that immun cells do not promote
wound healing and their depletion can even enhance it
[1,8]. Thus, models of embryonic wound healing will
evidence gene regulations that are crucial for the healing
process and independent from the perturbation induced
by immunocompetent cells. However, neutrophile-like
inflammatory cells and monocyte-like cells are accumu-
lated in growth factor-stimulated CAM which may par-
ticipate in the wound healing process [9].
Kilarski et al. [10] have developed a method to investi-
gate GT formation in the CAM. This model has allowed
a better understanding of the formation of the vascula-
ture during GT formation [10]. The major advantages of
CAM wound healing model is that the CAM is com-
posed of blood vessels and enclosed within 2 layers of
epithelium and a fibroblast matrix. This is in contrast to
a skin model, for example, where there are multiple cell
and tissue types (epidermis, dermis and subdermis).
Wound healing in the CAM model reflects primary
changes in vasculature and in stromal fibroblasts that is
not affected by “noise” from other cell types. Further-
more, a matched control can be obtained from the same
CAM.
Modern functional genomics approaches may facili-
tate a better understanding of the molecular events
involved in tissue morphogenesis and allow the identi-
fication of molecular signatures and pathways. We
have recently applied transcriptomic profiling to eluci-
date the molecular signatures involved in the develop-
ment of the normal chicken chorioallantoic membrane
and in tumors engrafted onto the CAM [11,12].
Furthermore, engraftment of human tumour tissue
onto the CAM, followed by transcriptomic analyses
with both human and chicken microarrays, enables the
gene signatures of both the host stroma and the
human tumour to be distinguished. We have now
extended our earlier studies by performing a transcrip-
tome analysis in the “wound model” of the chicken
CAM. This has allowed us to identify gene signatures
involved in GT formation and neoangiogenesis. These
results further indicate that the chicken embryo model
is an excellent tool for discovering networks that are
associated with granulation-tissue formation and tissue
repair.
Results and Discussion
Wound induction in the chicken CAM
Chick embryos were cultured for 10 days and CAMs
were inflicted by parallel scalpel superficial cuts of 1 cm
area, followed with a subsequent scarping off of the
epithelium of the injured chorioallantoic membrane.
The wound area was then covered with 1.5 cm square
nylon grid (figure 1A). As seen in figure 1B, significant
GT was formed and grew through the nylon grid in
response to injury. This GT contained a significant
amount of blood vessels with abnormal morphology
(tortuous blood vessels). Newly formed blood vessels
within the CAM became functional since injection of
Indian ink clearly evidenced newly perfused blood
vessels in the GT (figure 1C).
The CAM wound model has been established to ana-
lyze GT formation and the role of invading fibroblasts
and blood vessels in this process [10]. It has been found
that tissue tension generated by activated fibroblasts or
myofibroblasts during wound contraction, mediated and
directed translocation of the vasculature. This vascula-
ture can be expanded secondarily by elongation and ves-
sel enlargement, and finally, through splitting and
sprouting. To verify the presence of myofibroblasts in
our experimental set up, we performed immunohistol-
ogy using anti-a2-somooth muscle actin antibodies. The
invasion of a2-smooth muscle (a2-SM) actin positive
myofibroblasts and of blood vessels in the wounded area
was clearly visible and is depicted in figure 2.
Other chick wound models that have been proposed
such as epithelial regeneration models at the surface of
the embryo such as at the wing bud or the midbrain
region [8,13,14]. These models have helped to charac-
terize some of the morphological and molecular events
occurring during embryonict i s s u er e p a i ri n v o l v i n g
actin cable assembly and the Rho kinases [8,14]. Tissue
wound contraction is present in this model to some
extent, however without the presence of a2-SM posi-
tive myofibroblasts [8]. Another model is characterized
by the removal of only the peridermal layer. Wound
closure in this model is essentially driven by the
conversion of the basal layer, from monolayer to multi-
layer [15].
The advantage of our model is that it clearly distin-
guishes between preexisting and newly formed tissue
and vasculature and that an ingrowth of a2-SM actin
positive myofibroblasts is observed. Furthermore,
recruitment and translocation of the vasculature in the
wound area can be clearly envisioned. This allows us to
perform transcriptomic analysis after wounding to estab-
lish which genes are important players in this process.
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We therefore extracted RNA from eggs 6 days post-
wounding. We also extracted RNA from areas where no
injury was inflicted to the CAM from the same eggs.
Thus, each wound had a matched control from the
same egg and three eggs were used for hybridization on
each chip with their own controls (6 samples in total).
Data were normalized using the robust multi-averaging
method, part of the Affymetrix library in the statistical
programming language R. Hierarchical clustering,
performed on the three wounded and non-wounded
samples, indicated separate clustering of wounded and
non-wound CAM tissue (figure 3A). This indicates good
quality of the samples collected and of hybridizations.
We observed a total of 282 genes up-regulated and 44
genes down-regulated, applying a FDR < 5% and a fold
change > 2 (figure 3B).
Up-regulation as high as 79 fold was observed. Among
the most up-regulated genes, we observed: fatty acid
binding protein 4 FABP4 (79 fold), retinol binding pro-
tein 7 (RBP7) (74 fold), transthyretin (TTR) (37fold),
osteopontin (SPP1) (30 fold), neutrophile cytosolic factor
(NCF2) (25 fold), chemokine ah221 (LOC417536)
(10 fold) and cysteine-rich secretory protein (CRISP3
(8 fold)) (Table 1). Among the most down-regulated
genes, we observed: inter-alpha (globulin) inhibitor H5
(ITIH5) (0.11 fold), Collagen type VIII a1 (0.15 fold), tes-
tican (SPOCK1) (0.29 fold), Atonal homolog 8 (ATOH8)
(0.29 fold), laminin a1 (LAMA1) (0.32 fold), CXCL12
(0.32 fold), C1q and TNF-related protein 1 (C1QTNF1)
(0.32 fold) and plexin A2 (PLXNA2) (0.33 fold) (Table 2).
In order to analyze potential functional trends in the
gene lists identified, we performed a functional analysis
of the lists of differentially expressed genes. With the
Figure 1 Wound Model of the chicken chorioallantoic membrane. Panels A and B of this figure display granulation tissue 6 days after injury
(B is a larger magnification of A). In panel C, also showing granulation tissue 6 days after injury, Indian ink was injected to visualize perfused
blood vessels (vessels are now black).
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Page 3 of 17purpose to describe the overall representation of func-
tions differentially modulated in response to wounding,
we first computed the number of genes represented in
the most common gene ontology (GO) categories. As
seen in figure 4, the most abundant categories found in
this analysis were “binding”, “catalytic activity”, “cell
part”, “cellular processes” and “metabolic processes”.
There was a slight preponderance of up-regulated genes
within the first three categories. However, within “meta-
bolic processes” the majority of genes were up-regulated
rather than down-regulated.
Furthermore, differences in four other categories
related to extracellular matrix and adhesion (“biological
adhesion”, “extracellular matrix”, “extracellular region”
and “extracellular region part”)w e r eq u i t es t r i k i n g .I n
these categories, down-regulated genes were much more
abundant. In addition to this analysis, and in order to
identify functional categories enriched in our gene lists,
we also performed a functional analysis using the web
based tool, DAVID [16,17]. This procedure clusters
genes with similar functions (defined by similar Gene
ontology or KEGG pathway terms) into annotation clus-
ters (Additional file 1). It then assesses whether these
“functional clusters” are over-represented in the list of
genes differentially regulated. We submitted the up and
down regulated genes separately and summarized the
results in table 3. Due to the relatively low number of
significant genes at 5% FDR level, we have also verified
that results of the analysis were similar at less stringent
FDR thresholds (10% and 15%FDR). Generally no new
functions emerged when the FDR was increased but as
expected, each function increased in significance and
enrichment.
The expression of a number of cytokines or chemokines
was up-regulated after wounding. Some of them are
represented in the GO term “Cytokines-Chemokines”.
Among the others clearly associated with this category
are IL10R, IL4R, chemokine ligand 20 (CCL20),
CX3CR1 and IL1b. Components of the major histocom-
patibility complex (MHC) were also found up-regulated
Figure 2 Histology and immunohistology in the wound model. Wounding is performed as indicated in Methods and analyzed by histology
and immunohistology. Panel A and B, immunohistological analysis of a2-smooth muscle actin (anti-a2-SM antibody) in red, vessels are stained
in green (SNA-isolectin) and nuclei in blue (Dapi) of two different areas of the wounded CAM (10× magnification). Panel C, Hematoxylin-eosin
staining (10× magnification. Panel D is a higher magnification (20× magnification) of B. Scale bars, 100 μm. The figure clearly shows the
infiltration of a2-SM positive myofibroblasts and of blood vessels in the wounded area. The grid is visible in blue (A), or as black (B,D) and white
holes (C) or in rosa (C).
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Page 4 of 17Figure 3 Global analysis of the transcriptomic data. Panel A displays hierarchical clustering of the wounds versus the control microarray
results. In panel B, the quantitative representation of up and down-regulated genes in granulation tissue in comparison with control tissue is
displayed.
Table 1 List of 20 most induced genes in granulation tissue
Affymetrix ID UniGene
ID
Gene Name Gene
Symbol
Fold
Change
Gga.4939.1.S1_s_at Gga.4939 fatty acid binding protein 4, adipocyte FABP4 79.23
Gga.9386.1.S1_at Gga.9386 retinol binding protein 7, cellular RBP7 73.82
Gga.17686.1.S1_at Gga.41504 keratin 75 KRT75 59.38
Gga.2620.1.S1_at Gga.2620 transthyretin TTR 36.7
Gga.3551.1.S1_at Gga.3551 secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte
activation 1)
SPP1 30.01
Gga.17647.1.S1_at Gga.34552 neutrophil cytosolic factor 2 (65 kDa, chronic granulomatous disease, autosomal 2) NCF2 25.09
Gga.7228.1.S1_at Gga.7228 carboxymethylenebutenolidase homolog (Pseudomonas) CMBL 14.33
Gga.11640.1.S1_at Gga.11640 succinate receptor 1 SUCNR1 11.04
GgaAffx.10393.1.
S1_at
Gga.46851 cytochrome b-245, beta polypeptide (chronic granulomatous disease) CYBB 10.25
Gga.9133.1.S1_at Gga.9133 Chemokine ah221 LOC417536 9.95
Gga.6239.1.S1_at Gga.6239 regulator of G-protein signalling 1 RGS1 9.28
Gga.11456.1.S1_at Gga.11456 cystatin A (stefin A) CSTA 9.25
Gga.3383.1.S1_at Gga.3383 lipopolysaccharide-induced TNF factor LITAF 9.16
Gga.729.1.S1_at Gga.729 mature avidin LOC396260 8.41
Gga.1158.3.S1_a_at Gga.1158 HOP homeobox HOPX 8.41
GgaAffx.6592.1.S1_at —— — 8.36
GgaAffx.25031.1.
S1_at
Gga.19498 cysteine-rich secretory protein 3 CRISP3 8.29
Gga.17679.1.S1_s_at Gga.39008 similar to immunoglobulin-like receptor CHIR-AB3 -B4 -B5 -B LOC425449 8.2
GgaAffx.11785.1.
S1_s_at
Gga.9879 lipase A, lysosomal acid, cholesterol esterase (Wolman disease) LIPA 8.17
Gga.5743.1.S1_at Gga.5743 lymphocyte antigen 96 LY96 8.09
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Page 5 of 17after wounding. The latter may represent antigen pre-
sentation as a consequence to injury. This transcrip-
tional response is not likely to be part of the immune
system but may be associated to other cellular types of
the GT such as endothelial cells or fibroblasts. Interest-
ingly, the expression of some components of the extra-
cellular matrix and genes involved in developmental
processes were decreased. These include Wingless-type
MMTV integration site family member 2B (WNT2B),
fibrillin-1(FBN1), laminin-a1( L A M A 1 ) ,c o l l a g e nV I I I
(COL8A1), FRAS1-related extracellular matrix-1
(FREM1), Cysteine-rich transmembrane BMP regulator
1 (CRIM1), Semaphorin 3G (SEMA3G) or Eph receptor
A7 (EphA7). This indicates that synthesis of these com-
ponents is no more required when significant GT for-
mation has occurred. For the list of individual genes
represented in our gene lists and belonging to these
enriched categories, see additional files 2 and 3.
Network analysis of genes modulated in response to
wounding
In order to identify the structure of regulatory networks
underlying response to wounding we performed Ingenu-
ity Pathway Analysis (IPA). IPA identifies gene interac-
tion networks representing potential regulatory
pathways by integrating lists of differentially expressed
genes with a vast public domain literature database,
representing several types of gene-gene interactions.
Contrary to gene ontology analysis IPA networks repre-
sented gene interactions linked to specific mechanisms
(e.g. transcriptional activation, protein-protein interac-
tions, etc).
Additional file 4 summarizes the results of this analy-
sis by listing the most significant networks identified.
The Ingenuity category with the best scores (> 20) were
“Cardiovascular disease, organismal injury, tissue mor-
phology” (score: 50), “Free Radical Scavenging, Cellular
Movement, Hematological System Development and
Function» (score: 45), « Inflammatory Disease, Respira-
tory Disease, Carbohydrate Metabolism » (score: 37),
« Cellular Development, Hematological System Develop-
ment and Function, Immune and Lymphatic System
Development and Function » (score: 31), « Lipid Meta-
bolism, Small Molecule Biochemistry, Vitamin and
Mineral Metabolism » (score: 24), « Cancer, Immune
and Lymphatic System Development and Function,
Gene Expression » (score: 22).
The most significant networks identified with the best
IPA scores are Network 1, 2, 3 and 4 (figures 5A-D).
N e t w o r k1a n d2r a n kt o pi nt h eI P As c o r ea n dr e f l e c t
gene regulations involved in organismal injury, tissue
morphology and cellular movement such as IL1, IL1b,
I T G B 2 ,P D G F B B ,R a c ,R a s ,M M P 9 ,P P A R ,S E R -
PINB2&B5, IL1RAP or CXC3CR1. Network 3 depicts
several genes that are involved in cell cycle regulation
(cyclines A, E), cell movement (CD44, caspase). Network
4 involves regulations implicated in cellular development
and cell-cell interactions (IL8, IL2R, IFN-g etc). The
represented networks are associated with the production
and response of cytokine components. More specifically,
Table 2 List of 20 most down-regulated genes in granulation tissue
Affymetrix ID UniGene ID Gene.Name Gene Symbol Fold Change
Gga.9732.1.S1_at Gga.43260 inter-alpha (globulin) inhibitor H5 ITIH5 -9.09
Gga.3013.1.S1_at Gga.3013 collagen, type VIII, alpha 1 COL8A1 -6.67
Gga.3652.1.S1_at Gga.3652 C-type lectin domain family 3, member B CLEC3B -4.35
GgaAffx.8087.2.S1_s_at —— — -4.17
Gga.15966.1.S1_at Gga.35123 ankyrin 2, neuronal ANK2 -3.85
Gga.9166.1.S1_at Gga.9166 Finished cDNA, clone ChEST252j10 — -3.57
Gga.16835.1.S1_at Gga.15599 sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 SPOCK1 -3.45
Gga.8360.1.S1_at Gga.36205 Atonal homolog 8 (Drosophila) ATOH8 -3.45
GgaAffx.26547.1.S1_at —— — -3.33
Gga.170.1.S1_at Gga.170 wingless-type MMTV integration site family, member 2B WNT2B -3.33
Gga.6141.1.S1_at Gga.6141 immunoglobin superfamily, member 21 IGSF21 -3.33
Gga.12209.1.S1_at Gga.12209 Chromosome 4 open reading frame 31 C4orf31 -3.12
GgaAffx.24366.1.S1_at Gga.23904 laminin, alpha 1 LAMA1 -3.12
Gga.9513.1.S2_at Gga.9513 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) CXCL12 -3.12
GgaAffx.7505.1.S1_at Gga.29269 C1q and tumor necrosis factor related protein 1 C1QTNF1 -3.12
Gga.19875.1.S1_at Gga.23851 plexin A2 PLXNA2 -3.03
Gga.8241.1.S1_at Gga.8241 transcription factor 21 TCF21 -2.86
Gga.9024.1.S1_at Gga.43042 chromosome 8 open reading frame 22 C8orf22 -2.86
Gga.618.1.S1_at Gga.43121 cytochrome P450 1A4 CYP1A4 -2.78
GgaAffx.3294.1.S1_at Gga.37857 similar to SYT9 protein LOC423026 -2.7
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Page 6 of 17Figure 4 Gene ontology. This figure portrays the gene ontology of up and down-regulated genes in granulation tissue in comparison with
control tissue. Numbers represent the percentages of genes identified associated with a biological process, a cellular component or a molecular
function.
Table 3 DAVID analysis summary
UP LO
Enrichment
Score
Function Enrichment
Score
Function
4.64 antigen processing and presentation pf petide or polysaccharide antigen via MCH
class II
2.55 Extracellular matrix
2.43 phosphoinositide binding 1.06 Developmental
process
2.28 transmembrane
1.9 Cytokine/chemokine activity
This table shows a summary of the DAVID analysis. The functional terms most representing the annotation cluster is shown in columns 2 and 4 with the
respective enrichment scores in columns 1 and 3. The higher the enrichment score, the more interesting the enriched function.
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Page 7 of 17network 1 and 2 show the importance of IL-1 in the
response to wounding. Our results suggest that role for
this cytokine in the development of tissue repair and
possibly in the onset of angiogenesis. It is known that
IL-1b interacts with endothelial cells and induces VEGF
and iNOS expression [18]. IL-1b also signals through
IRAKs in vascular endothelial cells and induces genes in
the VEGF pathway [19,20]. Furthermore, IL-1b induces
fibrosis after radiation in experimental models, which
indicate a possible interaction of IL-1b with fibroblasts
[21]. In addition, IL1b concentrations are elevated in
chronic wounds in patients [22]. Thus, IL-1b may regu-
late fibroblast proliferation and migration during GT
formation. Among the other central cytokines are IL-8
and interferon-g (network 4 and 6, see also additional
file 5). The interaction of these cytokines with the vas-
culature and the stroma is well established [23,24].
Furthermore, IL-8 expression is elevated in chronic
wounds but not acute wounds, which supports a role of
this cytokine in GT formation [22]. IL-8 is a powerful
angiogenic chemokine implicated in vessel formation in
cancer, tissue repair and inflammation. It stimulates
VEGF expression and autocrine activation of VEGFR2
in vascular endothelial cells [25]. Interferon-g may inter-
act with stroma fibroblasts and paradoxically negatively
impact on angiogenesis [26]. It has been described that
the induction of the CXC chemokine interferon-g-indu-
cible protein-10 (IP10) regulates the reparative response
following myocardial infarction [27]. Interferon-g may,
thus, modify the cellular composition of the healing
Figure 5 A-D: Representation of 4 networks (Networks 1, 2, 3 and 4) derived from the Ingenuity Pathway Analysis (IPA).T h i sf i g u r e
displays an analysis, which depicts the central role of cytokines in granulation tissue and wound healing. The network categories are indicated
in each figure. A, Network 1 (up-regulated genes) Cardiovascular Disease, Organismal Injury and Abnormalities, Tissue Morphology; B, Network 2
(up-regulated genes): Free Radical Scavenging, Cellular Movement, Hematological System Development and Function; C, Network 3 (up-
regulated genes): Inflammatory Disease, Respiratory Disease, Carbohydrate Metabolism; D, Network 4 (up-regulated genes): Cellular Development,
Hematological System Development and Function, Immune and Lymphatic System Development and Function.
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Page 8 of 17tissue and promotes wound contraction, attenuating
adverse remodelling.
Expression analysis of some of the identified genes
The expression of 9 of the differentially regulated genes
in the Affymetrix analysis was then investigated by
quantitative real-time polymerase chain reaction (qRT-
PCR) in wound tissue in comparison to its own control
CAM (figure 6). We chose to analyze these genes
because of their expression levels and because not much
is known about their involvement in angiogenesis or tis-
sue repair. Transcript levels, as determined by qPCR,
were in accordance with the results obtained by the
Affymetrix analysis. The respective expression levels
were: FABP4 (100.5 fold), ah221 (35.4 fold), HOPX
(3.3 fold), TTR (109 fold), CCL20 (37.5 fold), MSLN
(5.5 fold), TCF21 (- 3 fold), ITH5 (-8.4 fold), and
SPOCK1 (-4.5 fold). Control and wound samples from
9 eggs were analyzed.
We then analyzed expression of the different genes
using GenePaint http://www.genepaint.org, ProteinAtlas
http://www.proteinatlas.org and Geisha http://www.gei-
sha.arizona.edu. In GenePaint, FABP4 was expressed in
the vasculature in the stage 14.5 mouse embryo. Signifi-
cant staining was seen in blood vessels (figure 7A to
7C), especially in the kidney (figure 7C). For compari-
son, the pattern of staining as seen in the kidney is iden-
tical to that of VE-Cadherin (CDH5), which is a specific
marker of blood vessels (figure 7D). Furthermore, in the
ProteinAtlas, staining of FABP4 was also seen in the
vasculature of several organs such as the urinary bladder
(figure 7E) but it is of note that not all blood vessels are
stained for FABP4. There is currently only one publica-
tion describing the expression of FABP4 in the vascula-
ture [28]. Our results are in agreement with these
findings and indicate a strong expression of FABP4 after
wounding. Chemokine ah221 is also significantly
expressed after wounding. The human ortholog of
ah221 is not yet identified but a similarity of 43% to
human CCL3 is observed. CCL3 has leukocyte chemo-
tactic activity and is involved in the recruitment of leu-
cocytes and fibroblasts into neoangiogenic sites such as
tumors [29]. CCL3 has also been shown to be produced
by endothelial cells and to have an autocrine function
[30]. It is likely that ah221 or its human ortholog has
similar functions and plays a significant role in wound
repair. HOPX is up-regulated 8.41 fold in our transcrip-
tomic analysis. This gene is expressed during cardiac
development, in various tumors, such as choriocarci-
noma, and it is likely it may have a function in tissue
repair as well [31,32].
Transthyretin (TTR) has been found highly up-regulated
in our analysis. Transthyretin (TTR) is a plasma protein
mostly known for being the transporter of thyroxine and
retinol [33,34]. When mutated, TTR is also well-described
as the cause of familial amyloid polyneuropathy, a neuro-
degenerative lethal disorder characterized by systemic
deposition of TTR amyloid fibrils [34]. A potential role in
tissue repair has not yet been described for this gene but it
may have an indirect effect on tissue morphogenesis
Figure 6 Expression analyses of selected genes. This figure shows the Quantitative Polymeras eC h a i nR e a c t i o n( q P C R )o fs e to fs e l e c t e d
genes. FABP4, ah221, HOPX, TTR, CCL20, Msln, TCF21, ITIH5 and SPOCK1 gene expression was analyzed in 9 samples of wound and in the 9
corresponding controls. For each CAM the fold change in the wound was calculated from the ΔΔCt and plotted. We normalized these genes
with the house keeping gene gHNRPH1 (Heterogeneous nuclear ribonucleoprotein H1) in all the tissues. A, upregulated genes; B, down-
regulated genes.
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Page 9 of 17through retinol. This is supported by our IPA (Additional
file 5, Network 6) where 15 genes up-regulated in the
wound are known to be directly induced by retinoic acid.
CCL20 (MIP-3 a) is a CC chemokine family member
that is highly expressed in our wound transcriptomic
analysis. CCL20 activates CCR6 and leads to calcium
mobilization and elevated active RhoA, phosphorylated
myosin light chain, and F-actin accumulation and stimu-
lation of epithelial cell migration [35]. Furthermore, in
rat models of oral wound healing, CCL20 is up-regu-
lated during the peak phase of wound healing [36].
These findings, together with ours, support an impor-
tant role of this chemokine in wound healing.
Mesothelin (MSLN) is also significantly up-regulated
after wounding. This is surprising since MSLN up-regu-
lation is mainly found in mesothelioma, pancreatic,
breast and ovarian carcinoma, and tumors of the GI
tract http://www.proteinatlas.org. In normal tissue,
significant expression is only observed in the fallopian
tube http://www.proteinatlas.org. It has been shown that
MSLN can interfere with cell cycle regulators by activat-
ing ERK kinase and decreasing BIM [37]. Furthermore,
an increase in Stat3 activation and cyclin E in MSLN
transfected pancreatic tumor cells is observed [38]. As
in tumors, MSLN may promote GT formation by pro-
moting proliferation of stromal fibroblasts and vascular
cells.
TCF21, which is decreased by 3 fold in our qPCR ana-
lysis, has been implicated in kidney and lung organogen-
esis [39]. TCF21 -/- die in the early perinatal period
because of multiple renal defects. TCF21 has also been
described as a tumor suppressor gene that undergoes
epigenetic modifications [40]. TCF21 has been impli-
cated in myofibroblast differentiation and control of
proliferation in mesenchymal progenitor cells [41].
During development, TCF21 is expressed at various
sites in the chick embryo such as the pericardium or the
allantois (figure 7H). During wound healing, TCF21 may
be implicated in the regulation of fibroblast proliferation
and differentiation in the GT. Inter-a globulin inhibitor
5 (ITIH5) decreased by 8.4 fold in our qPCR analysis,
encodes one of the heavy chains of ITI, It is a protease
inhibitor associated with the extracellular matrix and
contributes to matrix stability by covalent linkage to
Figure 7 Analysis of selected genes by in situ hybridization. The expression patterns of FABP4, as analyzed by in situ hybridization of mouse
E14.5 embryo, are displayed in panels A, B and C and the same for EMP-1 in panels F and G. Panels C and D, for direct comparison, show the
expression patterns of FABP4 and CDH5 respectively in kidney. Panel E shows the expression profile of FABP4 in vessels of the urinary bladder as
analyzed by immunohistochemistry. Panel G portrays the expression of EMP-1 in the endocard of an E14.5 embryo (in situ hybridization). Panel H
depicts the expression of TCF21 in the E23 chick embryo (in situ hybridization).
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various human solid tumors [42]. Furthermore, its loss
by promoter hyper-methylation is associated with poor
prognosis in mammary carcinoma [43]. During wound
healing, this molecule is possibly involved in matrix
remodeling. SPOCK1/SPARC/Osteonectin/testican-1 is
decreased by 4.5 fold in our qPCR analysis. This mole-
cule is a proteoglycan able to inhibit proteases such as
MMP2 or Catepsin L [44]. SPOCK1 is also expressed in
cancer associated fibroblasts where it reflects EMT [45].
However, SPOCK1 by itself inhibits angiogenesis,
enhances tumor stroma formation and prevents fibro-
blast activation [46]. This may further explain its anti-
tumor effect. Down-regulation of SPOCK1, as observed
in our study, may contribute to an increase in vessel
ingrowth and fibroblast activation during GT formation.
In silico-endothelial data filtering
Herbert and coll. have developed a method to assign
endothelial cell signatures to genes identified after gene
profiling studies [47]. Endothelial cell data filtering evi-
denced several genes with significant endothelial cell sig-
nature (Table 4). For FABP4, despite the fact that
endothelial transcript counts were not high, differences
were significant because no counts were observed in the
non-endothelial cell pool. As indicated previously, vas-
cular endothelial cell expression of this molecule is very
pronounced. For example, FABP4 is found in the vascu-
lature at E14.5 (figure 7B).
The molecule with the highest endothelial transcript
counts was epithelial membrane protein-1 (EMP1).
EMP1 was induced in our transcriptomic analysis by
about 3.3 fold in the GT after wounding. In GenePaint,
expression of EMP1 was seen in vascular cells and
possibly in the mesenchyme (figures 7F and 7G).
Expression is much more diffuse than that of FABP4.
EMP-1 is however, highly expressed in the endothelial
cell lining of the endocard (figure 7G). There is only
one single publication that reports EMP1 to be present
at tight junctions in vascular endothelial cells [48]. This
observation fits well with a role of EMP1 in tissue
repair, since endothelial cell junctions are remodeled
during endothelial cell migration in the GT.
Another gene highly expressed in endothelial cells was
MYCT1. MYCT1 is a direct target of c-myc and pheno-
copies many of the effects of c-myc [49,50]. It has been
described to be over-expressed in gastric carcinoma
[51]. No publications with regard to endothelial cell
expression of this gene have been reported, which is
reflected by a surprisingly low Angioscore.
CCL20 exhibited a significant Endofactor and a high
Angioscore. It has been reported that endothelial cells
in culture express CCL20 upon thrombin stimulation
[52]. CCL20 seems to be implicated in endothelial cell-
lymphocyte interaction through CCR6 [53]. Lymphatic
endothelial cells have been reported to express CCL20
upon induction by lipoteichoic acid (LTA) [54]. How-
ever, there have been reports where expression of
CCL20 is outside the vasculature, such as in tumor cells
[55]. The reason for these differences is not known but
genome instability of tumor cells, leading to aberrant
CCL20 expression, could be the reason.
Integration into a general mechanism of wound repair
and granulation tissue formation
From our results, some hypothesis can be formulated of
how identified genes may fit into a general scheme of
wound repair and GT formation. Tissue repair- is
Table 4 Endothelial cell data filtering
Gene qvalue Endo Count Non-Endo Endo factor Up/Down Angioscore Fold change
EMP1 0.00 136 30 19.90593 Up 1 3.33
CD74 0.00 6 819 0.032169 down 10 6.28
MYCT1 0.00 16 0 ∞ Up 0 0.4
CCL20 0.00 8 0 ∞ Up 35 2.13
LCP1 0.00 1 60 0.073184 down 1 4.37
HLA-DPB1 0.00 0 42 0 down 2 4.56
PGD 0.00 13 10 5.708318 Up 10 2.52
GSTO1 0.00 14 13 4.728784 Up 2 4.3
LTA4H 0.00 9 5 7.903825 Up 0 2.55
FABP4 0.01 4 0 ∞ Up 6 79.23
RGS1 0.01 4 0 ∞ Up 6 9.28
CAP1 0.01 34 68 2.195507 Up 0
MGST1 0.01 0 28 0 down 4 2.56
CD44 0.01 22 37 2.610873 Up 60 5.62
The table depicts a list of genes with positive Endo factor. Genes are listed according to q-values. Fold changes derived from the transcriptomic analysis and the
Angioscore are also indicated.
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ingrowth of vessels and fibroblasts are driven through
growth factors and cytokines such as IL8, IL1 and
PDGFRB. Some additional chemokines including CCL20
or ah221 may also contribute to endothelial cell activa-
tion, vessel remodeling during wound healing and fibro-
blast recruitment. FABP4 may participate in wound
repair by promoting endothelial cell proliferation. EMP1
m a yb ei n v o l v e di nt h em o d u lation of intercellular
adhesion in vessels after endothelial cell activation and
participate in the mobility and sprouting of vessels in
the GT.
The expression of several matrix or matrix-associated
proteins (CL8A1, FBN1, Laminin-a1, FRAS-1, ITIH5
etc.) is likely to be modulated during wound repair and
is decreased when significant GT formation had
occurred. Down-regulation of SPOCK1, as observed in
our study, may contribute to an increase in vessel in
growth and fibroblast activation during GT formation.
During wound healing, TCF21 may be implicated in the
regulation of fibroblast proliferation and differentiation
in the GT, and ITIH5 is possibly involved in matrix
remodeling. Interferon-g may interact with stroma fibro-
blasts and modify the cellular composition of the healing
tissue, thus, promoting wound contraction, attenuating
adverse effects on remodeling.
It is possible that vitamin A has a role in wound heal-
ing [56] as it is interesting that three genes out of the
top four up-regulated in the wounded CAM (from 36
fold to 79 fold up-regulation) from this study are poten-
tially retinol related (FABP4, RBP7 and TTR). It has
been shown that TTR (Transthyretin) forms a complex
with Retinol Binding Protein (potentially RBP7 here) for
transport of retinol around the circulation [57]. In addi-
tion, retinol binding proteins have already been shown
to be differentially expressed in GT [58]. Retinol is a
precursor to retinoic acid, which acts as a steroid hor-
mone, targeting nuclear receptors of genes involved in
tissue morphogenesis [59]. It is possible this steroid
hormone could be delivered to cells bound to a RBP7-
TTR complex and be transported through the cell
membrane by FABP4. FABP4 could also deliver retinoic
acid to signalling molecules such as Retinoic acid recep-
tors (RARs), Peroxisome Proliferator-Activated Recep-
tors (PPARs) and nuclear response elements. Fatty acid
binding proteins have been previously shown to do this
[60]. This hypothesis is supported by previous work
that found the topical addition of retinoic acid, derived
from retinol, to genetically diabetic mice improves
wound healing [61] and that corneal endothelial healing
rates increase in the presence of retinoic acid [62]. The
participation of other molecules such as Mesothelin is
more difficult to envision because of lack of sufficient
functional data.
There have been several studies that report transcrip-
tomic profiling in wound tissue in different experimental
settings. These include, for example, the transcriptome-
wide analysis in excisional murine cutaneous wound
inflammation [63]or in chronic ischemic wounds in the
pig model [64]. These studies are different to ours
because they are performed in an immunocompetent
setting and, thus, do not address exclusively the role of
the stromal fibroblasts and blood vessels. There has
been one study that performed a transcriptome-wide
analysis of blood vessels laser captured from human
skin and chronic wound-edge tissue [65]. However, in
this case contamination by circulating mononuclear cells
can also not not be excluded. There have also been
transcriptomic profiling studies using models of tissue
regeneration such as regeneration of Xenopus laevis hin-
dlimbs [66]or fin regeneration in the medaka fish [67].
These studies are different from ours because myofibro-
blast invasion does not occur in these models. Our
study is complementary to these existing transcriptome
profling studies and provides additional informations on
the gene networks implicated in wound repair and GT
formation.
Conclusion
The CAM wound model has been established to ana-
lyze GT formation and the role of invading fibroblasts
and blood vessels in this process [10]. It has been
found that tissue tension generated by activated fibro-
blasts or myofibroblasts during wound contraction,
mediated and directed translocation of the vasculature.
This vasculature can be expanded, secondarily by elon-
gation and vessel enlargement, and finally through
splitting and sprouting. We report herein a complete
transcriptome analysis of the “wound model” in the
chicken CAM, which allowed the identification of gene
signatures involved in GT formation and neoangiogen-
esis. Cytokines and chemokines clearly play a central
role as evidenced in our analysis. The limitation of our
work is that, contrary to the adult organism, our
model is devoid of immunocompetent cells [68].
However, it has been described that MMP-9 positive
neutrophile-like inflammatory cells and MMP-13 posi-
tive monocyte-like cells are accumulated in growth
factor-stimulated CAM [9]. Thus, these cells may also
participate, besides blood vessels and stromal fibro-
blasts, in GT formation after wounding in the CAM.
Another possible limitation is the relevance of our
findings for the mammalian setting. Indeed, it is known
that some of the regulators identified in the mammalian
system that are involved in vascular development are
not present in the chick such as the VE-statins [69].
However, this is a general problem for every model
organism including murin models. As an example,
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panzee. CXCL4L1 is a potent angio-inhibitory chemo-
kine that has potent inhibitory activity across species.
Furthermore, our laboratory has performed molecular
profiling studies using human xenograft tissue in the
chick CAM and identified gene regulatory mechanisms
relevant for the mammalian setting [12,70]. Thus, we
believe, that our results are of importance to the general
understanding of GT formation and tissue repair.
Methods
Tissue wounding
Brown Leghorn eggs were cultured at 38°C for 3 days. The
shells were then cracked and the contents transferred to
10 cm cell-culture Petri dishes. Embryo culture was con-
tinued for a another 7 days, when two injuries to the
CAM were inflicted by parallel scalpel superficial cuts of
1 cm area, with a subsequent scarping off the epithelium
of the injured chorioallantoic membrane. The wound area
was then covered with 1.5 cm square nylon grid and after
6 days, the CAM tissue (control and wound) were excised
and processed for subsequent analysis.
RNA isolation
Total RNA from cells or snap-frozen tissues were
extracted byusing RNeasy mini kit (Qiagen, Courta-
boeuf, France). RNA quality and quantity were assessed
by agarose gel electrophoresis and optical density mea-
surement. First strand cDNA was prepared from 1 μgo f
total RNA with Quantitect Reverse Transcription kit
(Qiagen). For all samples, a negative control was realized
with mRNA without reverse transcriptase in the reaction
mixture.
RNA was isolated from control and “wound” CAM
6 days after injury. Three eggs were used for indepen-
dent transcriptomic profiling. It is important to note
that from each egg, unwounded control CAM and
wound were analyzed. RNA was isolated according to
standard procedures and hybridized to Affymetrix
chicken GeneChips using the Affymetrix standard proto-
col (Affymetrix UK Ltd, High Wycombe, UK).
Transcriptome analysis
RNAs hybridized to Affymetrix chicken GeneChips
using the Affymetrix standard protocol (Affymetrix UK
Ltd, High Wycombe, UK). The chicken GeneChip cov-
ers 32773 transcripts, corresponding to > 28000 chicken
genes, and has a probe set oligonucleotide length of 25
and a detection sensitivity of 1:100000 http://www.affy-
metrix.com. Data were analyzed with the GCOS 1.2
software (Affymetrix), using the default analysis settings;
global scaling as first normalization method, with a
trimmed mean target intensity value (TGT) of each
array arbitrarily set to 100.
Gene expression profiles were identified using two-
class Significance Analysis of Microarrays (SAM)
method [71] (http://www-stat.stanford.edu/~tibs/SAM/,
which utilizes a Wilcoxon-test statistic and sample-label
permutation to evaluate statistical significance between
sample groups. SAM provides mean fold change values
(FC) (mean fold-change > 2) and a false discovery rate
(FDR) confidence percentage based on data permutation
(n = 200). The False Discovery Rate (FDR), an estimate
of the fraction of selective genes, was kept below 5% in
all statistical analyses.
Data analysis was done using the Gene ontology data-
base included in the statistical environment R library
GOstat http://www.geneontology.org and Ingenuity
Pathway Analysis (IPA) (Ingenuity Systems, Redwood
City, CA 94063) software. The functional clustering was
performed using the method implemented on the
DAVID website http://david.abcc.ncifcrf.gov/.
Annotation of genes was performed using NetAffx
http://www.affymetrix.com. The microarray data files
have be submitted to the US National Center for Bio-
technology Information, Gene Expression Omnibus
(GEO), and released in May 6
th, 2010 (GEO accession
number: GSE21679).
qPCR analysis
Real-time PCR was carried out in an Mx3000P thermo-
cycler (Stratagene, La Jolla, CA) by using SYBR Green
dye (ABgene, Courtaboeuf, France). Chicken-specific
primers were designed and respectively evaluated for
amplification efficiency using total RNA isolated from a
total chicken embryo on embryonic day 5. Only primers
pairs with amplification efficacy between 90 and 100%
were used. The PCR specificity was verified by dissocia-
tion curve analysis and agarose gel electrophoresis of
the amplification product.
The primer sequences are: gah221 forward
CTGGCCCTCTGCTCCTCA and reverse GGACGG-
GACGTTGAACATAG, gCCL20 forward CGGAAGGT-
CATTAAGGGC and reverse AAACCATATCACA
TTGACATCCTC, gFABP4 forward AGACTGC-
TACCTGGCCTGAC and reverse GCCATCTTCCTGG-
TAGCAAA, gHOPX forward GCAGTCACGCTGG
CTATAAA and reverse CCATTTCTCCTGGATGGTG,
gITIH5 forward TCTTGTTGCCCTTGGAAATC and
reverse TTCTTTCCTCCCACCTCCTT, gMsln forward
AAAATGAACAGGCTGCTGCT and reverse TCAGGC
TGTTGGGGTCTATC, gSPOCK1 forward AAAG-
CAGGGGACCGTTAGTT and reverse TTCCAAAT-
CATCCAGCAACA, gTCF21 forward CCATCCAG
TCAACCTGACCT and reverse AGCGGTTTGTGTT-
CACCACT, gTTR forward TTGATTCCAAATGCC
CTCTC and reverse TAGCAAAGTCCTGCCAGGTT
and the house keeping gene gHNRPH1 forward
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TTCGGCTGAGAGACAAT.
Predicting human ortholog of chicken genes
To concentrate on genes of importance to human
pathology and physiology, human orthologs of the
chicken genes present on the Affymetrix chicken Gene-
Chips were predicted using a Reciprocal Best Hit (RBH)
approach [72]. In this work, both human and chicken
Refseq nucleotide and protein sequences were down-
loaded from the NCBI on 30
th January 2008 ftp://ftp.
ncbi.nih.gov/refseq. Likewise, cDNA accession numbers
of sequences used to design the microarray probes were
extracted from Affymetrix chicken chip file “Chicken.
na22.annot.csv” http://www.affymetrix.com. Each cDNA
sequence, depending on the source of the probe design,
was downloaded from ENSEMBL or the NCBI, and, as
most of the cDNA sources were Expressed Sequence
Tags, full length chicken mRNAs were sought by
BLAST searching each of them against the Refseq
chicken nucleotide database. The resulting matches
were ranked as good, reasonable or bad, depending on
the alignment quality (Good: sequence alignment > 100
base pairs with a percent identity > = 96%. Reasonable:
a sequence alignment > 100 bases and a percent identity
> 90% and < = 95%. Bad: all other hits). The full length
chicken mRNA sequences ranked good and reasonable
were then used in a RBH analysis.
Defining chicken endothelial cell genes using human
orthologs and human cDNA library analyses
To identify which chicken genes could have an endothe-
lial cell expression signature, the human orthologs were
compared with the results from a novel in-silico bioin-
formatics screen, where an accurate EST-to-gene assign-
ment and a new likelihood ratio statistic were used to
find genes preferentially expressed in endothelial cells
using cDNA library analyses (see Herbert et al. 2008 for
a full description). The intersection of the comparison
were endothelial genes and only those genes [47] with a
q-value < = 0.01 were considered. An “Endofactor”
describes how significant a gene was endothelial as
found with the q-value.
Literature scanning of human-chick orthologs:
“Angioscore”
For all the genes found differentially expressed on the
chicken chip, a literature search of the human orthologs
of chicken genes were carried out to find those having
literature relating to relevant pathologies and physiolo-
gies. To accomplish this, Perl scripts were written that
searched article abstracts for the following keywords
typical of angiogenic research. They were “angiogenic”,
“angiogenesis”, “neovascularis(z)ation”, “vasculogenesis”,
“vascular”, “VEGF”, “hypoxia” and “endoth” (for
endothelial or endothelium).
Expression analysis
In situ hybridization and immunostaining data were
retrieved from the Genepaint data base (Max-Planck-
Institute of Biophysical Chemistry, Dept. Genes and
Behavior, 37077 Goettingen Germany; http://www.
genepaint.org; figure 7A to 7 D ,Fa n d7 G ) ,P r o t e i n a t l a s
(AlbaNova University Center at the Royal Institute of
Technology, Stockholm, Sweden, the Rudbeck Labora-
tory, Uppsala University, Uppsala, Sweden and Lab
Surgpath, Mumbai, India; http://www.proteinatlas.org;
figure 7E) and the GEISHA database (University of
Arizona, Tucson, AZ 8572; http://geisha.arizona.edu
[73]; figure 7F).
Histology and Immunohistology
Wound areas were fixed for at least 24 hours in a Zn-
fixative [74]. Tissues were embedded in paraplast, and
section of 10 μmw i t haM I C R O MH M 3 2 5w e r ep e r -
formed and placed onto Super Frost slides. Dewaxed
slides were either stained with Weigert’s hematoxylin
and eosin or incubated 40 min at 95°C in a citrate buffer
for the antigen recovery before immunohistochemistry.
These slides were then fixed with 4% paraformaldehyde,
permeabilized with Triton-X100 (0.1%), saturated with
5% BSA in PBS (pH 7.4) and incubated with the primary
antibody over-night at 4°C (anti-human Smooth Muscle
actin, DAKO, IR611) This antibody also recognizes very
well the chicken protein. Secondary fluorescent anti-
mouse antibody was from Molecular Probes (used
at1:1,000, Invitrogen). Chick blood vessels were visua-
lized by using fluorescein-coupled Sambucus nigra lectin
(SNA-1 lectin, 1:100, Vector Laboratories). Cell nuclei
were visualized by DAPI (Invitrogen). Microphotographs
were taken with a Nikon eclipse E600 microscope
equipped with a digital camera Nikon DS-Ri1.
List of abbreviations
ATOH8: Atonal hololog 8; CCL: chemokine (CC motif)
ligand; CXCL: chemokine (C-X-C motif) ligand; CAM:
chorioallantoic membrane; C1q: Complement factor 1q;
CRISP3: cysteine-riche secretory protein; EMP1: epithe-
lial membrane protein-1; FABP4: fatty acid binding
protein-4; GT: granulation tissue; HOPX: Homeobox
PX; ITIH5: inter-a (globulin) inhibitor H5; LAMA1:
laminin a1; LTA: lymphotoxin alpha; MSLN: mesothelin;
MYCT1: myc target-1; NCF2: neutrophile cytosolic
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Additional material
Additional file 1: (additional Table S1): Clustering of genes with
similar function according to Gene Ontology terms.
Additional file 2: (additional Table S2): List of all up-regulated
genes (cut off > 2).
Additional file 3: (additional Table S3): List of all down-regulated
genes (cut off > 0.1).
Additional file 4: (additional Table S4): Ingenuity pathway analysis.
Regulated genes were analyzed by Ingenuity pathway analysis (IPA) in
order to determine functional categories. Functional categories are listed
in the tables that depict categories for up-regulated (A) or down-
regulated genes (B). As it can been seen in the tables, categories related
to tissue morphological processes have the highest Ingenuity scores.
Additional file 5: (additional Figure S1A-J): Representation of
networks from the IPA for up-(A-H) or down-regulated genes (I-J).
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